切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2010, Vol. 04 ›› Issue (04) : 319 -322. doi: 10.3877/cma.j.issn.1674-0793.2010.04.007

所属专题: 文献

论著

紫杉醇在大鼠原位肝移植中的作用及其对细胞毒性T淋巴细胞实验的影响
郭卫平1, 卫洪波1, 李玺1, 陈图峰1, 汪根树1, 陈规划1,()   
  1. 1. 510630 广州,中山大学附属第三医院普通外科
  • 收稿日期:2010-03-10 出版日期:2010-08-01
  • 通信作者: 陈规划

Effect of paclitaxol in rat orthotopic liver transplantation and its impact on the CTL

Wei-ping GUO1, Hong-bo WEI1, Xi LI-1, Tu-feng CHEN1, Gen-shu WANG1, Gui-hua CHEN1,()   

  1. 1. Department of Gastrointestinal Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2010-03-10 Published:2010-08-01
  • Corresponding author: Gui-hua CHEN
  • About author:
    Corresponding author: CHEN Gui-hua, Email:
引用本文:

郭卫平, 卫洪波, 李玺, 陈图峰, 汪根树, 陈规划. 紫杉醇在大鼠原位肝移植中的作用及其对细胞毒性T淋巴细胞实验的影响[J]. 中华普通外科学文献(电子版), 2010, 04(04): 319-322.

Wei-ping GUO, Hong-bo WEI, Xi LI-, Tu-feng CHEN, Gen-shu WANG, Gui-hua CHEN. Effect of paclitaxol in rat orthotopic liver transplantation and its impact on the CTL[J]. Chinese Archives of General Surgery(Electronic Edition), 2010, 04(04): 319-322.

目的

观察紫杉醇在大鼠原位肝移植中的作用及其对细胞毒性T淋巴细胞(CTL)的影响。

方法

建立Wistar→SD大鼠肝移植的急性排斥模型。将大鼠分为对照组(阻断全肝血流)、急排组(Wistar→SD肝移植)、紫杉醇组(Wistar→SD肝移植,紫杉醇腹腔注射0.75 mg·kg-1·d-1,观察生存时间、病理改变、生化指标及CTL、T淋巴细胞凋亡情况。

结果

紫杉醇组大鼠的术后存活时间高于急排组,[(18.2±1.5)d vs(8.8±1.9)d,P<0.01)。急排组的HE评分(Banff)高于紫杉醇组(7.80±0.83 vs 4.80±0.82,P<0.01)。紫杉醇组的白蛋白水平高于急排组(P=0.003);紫杉醇组的谷丙转氨酶水平低于急排组(t=25.23,P<0.01)。CTL检测中,急排组的特异性杀伤靶细胞的百分率均高于紫杉醇组(P<0.01)。急排组的T淋巴细胞的凋亡率低于紫杉醇组[(7.16±1.56)% vs(16.47±2.51)%,P<0.01]。

结论

紫杉醇在大鼠肝移植中具有免疫抑制作用,可能通过诱导T淋巴细胞凋亡来抑制T淋巴细胞的活化发挥作用。

Ojective

To observation of the effect of paclitaxol in rat orthotopic liver transplantation and its impact on the cytotoxic T lymphocyte (CTL).

Methods

Wistar → SD rat liver transplantation model of acute rejection was established. The rats were divided into three groups: control group (blocking total hepatic blood flow), acute rejection group (Wistar → SD liver transplantation), paclitaxel group (Wistar → SD liver transplantation, paclitaxel intraperitoneal injection of 0.75 mg·kg-1·d-1. The survival time, pathological changes, biochemical markers and CTL, T lymphocyte apoptosis were observed.

Results

The postoperative survival time of paclitaxel group were rats higher than acute rejection group, (18.2±1.5)d vs(8.8± 1.9) d, P<0.01. HE score (Banff) of acute rejection group is higher than the paclitaxel group, 7.80±0.83 vs 4.80±0.82, t=5.67, P<0.01. Albumin level in paclitaxel group ranked higher than acute rejection group, P=0.003, while alanine aminotransferase of paclitaxel group were lower than acute rejection group, P<0.01. In CTL, the percentage of anti-target cell in acute rejection group were higher than the percentage of paclitaxel group, P<0.01. Tlymphocyte apoptosis rate of acute rejection group isless than the paclitaxel group, (7.16±1.56)% vs(16.47±2.51)%, P<0.01.

Conclusion

Paclitaxel exerts immunosuppression in rat liver transplantation, by inducing T lymphocyte apoptosis to suppress T lymphocyte activation probably.

图1 对照组的病理结果(HE染色20×10)
图2 急排组的病理结果(HE染色40×10)
图3 紫杉醇组病理结果(HE染色20×10)
图4 各组在CTL特异性杀伤靶细胞的百分率
图5 对照组的T淋巴细胞凋亡情况(AnnexinV+PI-:5.21%)
图6 急排组的T淋巴细胞凋亡情况(AnnexinV+PI-:6.86%)
图7 紫杉醇组的T淋巴细胞凋亡情况(AnnexinV+PI-:17.51%)
1
Dezube BJ. New therapies for the treatment of AIDS-related Kaposi sarcoma. Curr Opin Oncol,2000,12(5):445-449.
2
Figgitt DP, Wiseman LR. Docetaxel: an update of its use in advanced breast cancer. Drugs,2000,59(3):621-651.
3
Iesalnieks I, Tange S, Scherer MN,et al. Paclitaxel promotes liver graft survival in rats and inhibits hepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with liver cancer. transplant Proc,2002,34(6):2316-2317.
4
Tange S, Scherer MN, Graeb C,et al. The antineoplastic drug Paclitaxel has immunosuppressive properties that can effectively promote allograft survival in a rat heart transplant model. Transplantation,2002,73(2):216-223.
5
Lee M, Yea SS, Jeon YJ. Pachtaxel causes mouse splenic lymphocytes to a state hyporesponsiveness to lipopolysaccharide stimulation. Int J Immunopharmacol,2000,22(8):615-621.
6
Geissler EK, Graeb C, Tange S,et al. Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients. Hum Gene Ther,2000,11(3):459.
7
Reyes-Corona J, Gonzalez-Huezo MS, Zea-Medina MV,et al. Paclitaxel coated-stent for early-onset thrombosis after liver transplantation. Ann Hepatol,2007,6(4):272-275.
8
Lee BH, Lee JE, Lee KW,et al. Coating with paclitaxel improves graft survival in a porcine model of haemodialysis graft stenosis. Nephrol Dial Transplant,2007,22(10):2800-2804.
9
Le Moine A, Goldman M, Abramowicz D. Multiple pathways to allograft rejection. Transplantation,2002,73(9):1373-1381.
10
Yu B, Kusmartsev S, Cheng F,et al. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer. Clin Cancer Res,2003,9(1):285-294.
11
Vicari AP, Luu R, Zhang N,et al. Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse. Cancer Immunol,2009,58(4):615-628.
[1] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[2] 李坤河, 寇萌佳, 邝立挺. 肝移植术后二次气管插管的危险因素及预测模型的建立[J]. 中华普通外科学文献(电子版), 2023, 17(05): 366-371.
[3] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[4] 陆闻青, 陈昕怡, 任雪飞. 遗传代谢病儿童肝移植受者术后生活质量调查研究[J]. 中华移植杂志(电子版), 2023, 17(05): 287-292.
[5] 范铁艳, 李君, 陈虹. 肝移植术后新发戊型病毒性肝炎的诊治经验[J]. 中华移植杂志(电子版), 2023, 17(05): 293-296.
[6] 陈朔, 陈峰, 程飞, 项捷. 糖原累积病Ⅰ型并发胰腺炎肝移植术后胰腺梗死一例[J]. 中华移植杂志(电子版), 2023, 17(05): 300-302.
[7] 汤鹏昊, 张武. 肠道微生态与肝移植围手术期并发症相关研究进展[J]. 中华移植杂志(电子版), 2023, 17(05): 303-307.
[8] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[9] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[10] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[11] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[12] 王孟龙. 肿瘤生物学特征在肝癌肝移植治疗中的意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 490-494.
[13] 杨蕴钊, 周诚, 石美涵, 赵静, 白雪源. 人羊水间充质干细胞对膜性肾病大鼠的治疗作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 181-186.
[14] 萨仁高娃, 张英霞, 邓伟, 闫诺, 樊宁. 超声引导下鼠肝消融术后组织病理特征的变化规律及影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 394-398.
[15] 王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426.
阅读次数
全文


摘要